Company Search:
Advanced Search
Sponsored Links
Tty Biopharm Company Limited Company Snapshot
Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other companies in this sector in Taiwan: Sinphar Pharmaceutical C O., Ltd. (2015 sales of 2.19 billion Taiwanese Dollars [US$71.70 million] of which 66% was Medicine), Standard Chem. & Pharm. Co Ltd (3.32 billion Taiwanese Dollars [US$108.87 million] of which 66% was Standard), and Formosa Laboratories, Inc (2.60 billion Taiwanese Dollars [US$85.12 million] of which 100% was Active Pharmaceutical Ingredient).

Sales Analysis. Tty Biopharm Company Limited reported sales of 3.20 billion Taiwanese Dollars (US$104.74 million) for the year ending December of 2015. This represents an increase of 7.2% versus 2014, when the company's sales were 2.98 billion Taiwanese Dollars. The sales level in 2015 was fairly close to the level five years ago: in 2010, Tty Biopharm Company Limited had sales of 3.44 billion Taiwanese Dollars. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 225.0% in 2015, from 3.67 million Taiwanese Dollars to 11.92 million Taiwanese Dollars. Tty Biopharm Company Limited also saw significant increases in sales in Anti-Cancer Drug (up 49.5% to 2.08 billion Taiwanese Dollars) and Anti-Infection Drug (up 36.2% to 310.06 million Taiwanese Dollars) . Not all segments of Tty Biopharm Company Limited experienced an increase in sales in 2015: sales of Taipei Branch fell 66.5% to 206.57 million Taiwanese Dollars. Tty Biopharm Company Limited also experienced decreases in sales in Cardiovascular and Gastrointestinal Drug (down 8.6% to 513.65 million Taiwanese Dollars) and Mainland (down 60.3% to 70.57 million Taiwanese Dollars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tty Biopharm Company Limited
  Stock Performance Chart for Tty Biopharm Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 114.00
(Figures in Taiwanese Dollars)
1 Week -0.4%   13 Weeks 9.1%  
4 Weeks 22.6%   52 Weeks 9.1%  
Tty Biopharm Company Limited Key Data:
  Ticker: 4105 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,195,218,000
(Year Ending Jan 2016).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 28,346,100,000
  Fiscal Yr Ends: December Shares Outstanding: 248,650,000
  Share Type: Gu Closely Held Shares: 54,639,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.